XML 20 R7.htm IDEA: XBRL DOCUMENT v3.24.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ (DEFICIT) EQUITY - USD ($)
$ in Thousands
Total
Common Class A
Common Class B
Common Stock
Common Class A
Common Stock
Common Class B
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning Balance (in shares) at Dec. 31, 2021 [1]       4,668,678 134,839      
Beginning Balance at Dec. 31, 2021 $ 652,205     $ 47 [1] $ 1 [1] $ 1,672,588 $ (1,020,142) $ (289)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (140,671)           (140,671)  
Compensation expense related to granting of stock awards (in shares) [1]       40,606        
Compensation expense related to granting of stock awards $ 7,297         7,297    
Common stock repurchased (in shares) 0              
Issuance of common stock related to the ESPP (in shares) [1]       19,453        
Issuance of common stock related to the ESPP $ 429         429    
Purchase of vested employee restricted stock units, net (in shares) (23,000)     (23,409) [1]        
Purchase of vested employee restricted stock units, net $ (1,883)         (1,883)    
Payment of dividends on common stock (184)         (184)    
Dividend equivalents, net of forfeitures 195           195  
Net unrealized loss on derivatives 3,231             3,231
Ending Balance (in shares) at Dec. 31, 2022   4,705,328 134,839 4,705,328 [1] 134,839 [1]      
Ending Balance at Dec. 31, 2022 520,619     $ 47 [1] $ 1 [1] 1,678,247 (1,160,618) 2,942
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (1,136,871)           (1,136,871)  
Compensation expense related to granting of stock awards (in shares) [1]       181,499        
Compensation expense related to granting of stock awards 4,387     $ 2 [1]   4,385    
Issuance of common stock (in shares)       8,333        
Issuance of common stock $ 3         3    
Common stock repurchased (in shares) 0     (215)        
Purchase of vested employee restricted stock units, net (in shares) (28,000)     (27,775) [1]        
Purchase of vested employee restricted stock units, net $ (129)         (129)    
Payment of dividends on common stock (39)         (39)    
Dividend equivalents, net of forfeitures 219           219  
Net unrealized loss on derivatives (1,475)             (1,475)
Realized gain on derivatives, net (1,467)             (1,467)
Ending Balance (in shares) at Dec. 31, 2023   4,867,170 134,839 4,867,170 134,839 [1]      
Ending Balance at Dec. 31, 2023 $ (614,753)     $ 49 [1] $ 1 [1] $ 1,682,467 $ (2,297,270) $ 0
[1] Share counts have been retroactively adjusted to reflect the effect of the June 30, 2023 reverse stock split.